BACKGROUND: Neuromodulatory medications (NMs), such as amitriptyline, carbamazepine and gabapentin, are used as topical preparations for the management of neuropathic orofacial pain (NOP) and have produced promising preliminary results. The aim of this study was to investigate the effects of three aforementioned NMs on cell lines relevant to the orofacial tissues in vitro as no published studies have examined the effect of these topical NMs. METHODS: Cellular viability was measured using alamarBlue â , testing cumulative and specific time point effects of NMs on human skin keratinocytes and oral keratinocytes. Effects of the NMs on cell counts were investigated by CCK-8 assay. Drug concentrations released from NM orabase pastes after 30-min incubation were measured by high-performance liquid chromatography. Using these clinical concentrations, morphological changes and cytokine expression were investigated using scanning electron microscopy (SEM) and human inflammatory antibody array (AAH), respectively. RESULTS: Cumulative and specific time point viability and cell count methods revealed that amitriptyline caused a significant decrease in cellular viability and counts in both cell lines. Carbamazepine also had significant effects after long-term exposure and at higher concentrations, whilst gabapentin had little demonstrable effect. SEM confirmed the cytotoxicity of amitriptyline, whilst AAH revealed no significant changes in cytokine expression following amitriptyline, carbamazepine or gabapentin exposure compared with control. CONCLUSIONS: The results raise concerns about the safety of topical amitriptyline as it was cytotoxic to skin and oral keratinocytes in both exposure times and concentrations, whilst carbamazepine was cytotoxic only at high concentrations and after longer exposure times and gabapentin had no demonstrable effects.
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Introduction
Orofacial pain (OFP) is 'pain perceived in the face and/or oral cavity caused by diseases or disorders of regional structures, by dysfunction of the nervous system or through referral from distant sources' (1) . The pathophysiology of the persistent OFP is varied, but includes neuropathy (2) which can be due to macro-or microscopic trauma, a disorder, or a disease affecting the trigeminal nerve (3) . There are several persistent OFP conditions thought to be of neuropathic origin, including persistent dentoalveolar pain disorder (PDAP) and trigeminal neuralgia (4, 5) . Neuropathic pain affecting the trigeminal region is known to exert significant impacts on individual's daily lives (6) , and the following root canal treatment or extraction PDAP is thought to occur in 1.6% (7) of cases, whilst trigeminal neuralgia is thought to occur in 12.7 per 100 000 people (8) .
Contemporary evidence-based management of neuropathic pain suggests the sequential phases of treatment according to the primary diagnosis, efficacy and side effect profile of the medication(s) employed (9) . Core classes of medications recommended for their efficacy in neuropathic (orofacial) pain are antidepressants and anticonvulsants with evidence of their efficacy largely being derived from studies focussing on neuropathic pain elsewhere in the body (10) . Management of neuropathic OFP follows this evidence base, but one of the disadvantages of this approach is the necessity to deliver the medication systemically. This route of administration has concomitant side effects that are known to affect patient's adherence to drug regimens (6) . As opposed to systemic administration, topical administration of medication may help improve drug delivery to the site of need and also the side effect profile of the medication, thereby potentially improving adherence to and efficacy of therapy (11) . This approach has already shown promise in neuropathies using medications, such as capsaicin and lignocaine patches (12) . Sporadic reports of clinical experience employing compounded, topical, forms of antidepressants and anticonvulsants (neuromodulatory medication [NM] ) in neuropathic OFP have emerged in the literature with largely promising results (13, 14) . The analgesic effect of NMs is exerted through a number of therapeutic targets: amitriptyline has a varied mode of action, but blocks several ion-gated channels (Na + , Ca ++ and K + channels), along with NMDA receptors, and modifies the function of adenosine receptors (15) (16) (17) ; carbamazepine primarily exerts its effect through blocking sodium channels; and gabapentin's mode of action is thought to be by blocking calcium channel subunit (a2d-1) (15, 18) .
Whilst hepatic, renal and neuronal tissue cytotoxicity testing has been conducted for the systemic administration of NMs, there are no such data for their topical application to orofacial tissues. The effect of NMs exposure on cytokine expression has been investigated only following the systemic administration and only in vitro. When examined in these studies, NM usage was found to be associated with suppression of specific pro-inflammatory cytokines (e.g. IL1b and TNF-a) and over expression of anti-inflammatory cytokines (e.g. IL-10) (19) (20) (21) (22) (23) (24) .
This study investigates the effects of three NMs (amitriptyline, carbamazepine and gabapentin) on the relevant oral and skin cell line models and provides preliminary data on drug release from common compounded formulations of these drugs in vitro.
Materials and methods
Four groups of experiments were conducted as part of this paper:
1 Cell viability and median lethal dose. 2 Cell count. 3 Drug release and cellular morphology. 4 Cytokine expression.
The NMs included and their concentrations were decided after a literature search (13, 14) and an informal survey of the international members of the University of California, Los Angeles (UCLA) OFP listserve about the more common compounded medications used in NOP. The only exceptions to this were the cellular morphology and cytokine expression experiments, which used concentrations determined from the drug release experiment.
Keratinocyte non-cancer cell lines were utilized in this study as being representative of the target orofacial tissues and with the knowledge that these are accepted as giving comparative reproducible results, in cytotoxicity and dental biocompatibility investigations (25, 26) . The cell lines employed were as follows: immortalized skin keratinocytes (HaCat) (27) and immortalized keratinocyte cell line (OKF6-TERT1) from oral mucosa (28) .
Preparation of drug solutions
Pure amitriptyline hydrochloride, carbamazepine and gabapentin were obtained from Sigma-Aldrich, UK. Amitriptyline and gabapentin were dissolved in sterile deionized water to stock concentrations of 63.7 and 29.1 mM, respectively, before further dilution in fresh culture media to the working concentrations of 200 lM and 1.8 mM, and 150 lM and 5.54 mM, respectively. Carbamazepine was dissolved in 100% ethanol to a stock concentration of 84.6 mM before further dilution in fresh culture medium to two final working solutions of 100 lM and 1.7 mM (Table 1 , outlines the equivalent clinical concentrations of these laboratory values). The final concentration of ethanol was <2% in the final working solutions, and this concentration of ethanol alone did not affect the viability of any cell line. For antibody array experiments, serum-free media were used to prepare the drug solutions.
Cell culture
Immortalized HaCat cells (passage 67) and OKF6-TERT1 cells (passage 7) were maintained and passaged as described previously (28, 29) .
Cell viability and medial lethal dose
AlamarBlue â (AbD Serotec, Oxford, UK) was used to investigate the effect of NMs on cell viability in vitro. This test works by measuring the colour change from blue to pink as a result of resazurin's chemical reduction, in response to cellular metabolic activities during cellular growth and multiplication. This colour change was measured by absorbance at a wavelength of 570/600 nm.
Experiments examined the following: (a) cumulative effect of NMs on cellular viability and (b) the effect of NMs observed at specific time points of cellular exposure.
Median lethal dose (LD 50 ) was calculated using absorbance values obtained by the alamarBlue â method, using semi-log graph paper for all three drugs and for both . After incubation, the absorbance was measured after 30 min, 1-h, 2-h, 4-h and 24-h exposure using a plate reader (Synergy HT; BioTek, Winooski, VT, USA) at two wavelengths (570/600) nm. Effect of NMs at specific time points. HaCat and OKF6-TERT1 cells were seeded at densities of 1 9 10 4 and 2 9 10 4 cells/well, respectively, in 96-well plates containing fresh culture media up to a volume of 100 ll per well. Cells were incubated at 37°C overnight before media replacement with 100 ll of previously prepared media containing pure drug solution at the different low and high concentrations of amitriptyline, gabapentin or carbamazepine. After incubation for 30 min and 24 h, the effects of the NMs were stopped by washing the cells in phosphate-buffered saline (PBS) before further incubation with 100 ll of fresh media, plus 10% (v/v) alamarBlue â . Absorbance was measured after 4-h incubation.
Cell count
The CCK-8 assay (Dojindo Laboratories, Kumamoto, Japan) is based on cellular activity, specifically dehydrogenases and mitochondrial activity, resulting in reduction of tetrazolium salts (yellow) to formazan (orange) that can be quantified. The CCK-8 assay was used to investigate changes in cultured cell counts, in response to exposure to the NMs. HaCat and OKF6-TERT1 cells were seeded and treated as before alongside a range of control cells seeded at different cell densities to establish a calibration curve. After incubation for 30 min and 24 h, the effect of the NM was again stopped by washing the cells in PBS. Cells were then incubated with 100 ll fresh media plus 10% (v/v) CCK-8 reagent. Absorbance was measured after incubation for 150 min using a plate reader (BioTek) at 450 nm wavelength.
Drug release and cellular morphology
A sterile Orabase â paste without additives (ConvaTec, Deeside, UK) was mixed with the required amount of the pure medication powder using a doubling up technique (30) to prepare NMs at clinically published concentrations (13, 14) . Approximately 2 g from the resultant amitriptyline (2% w/v, 63.7 mM), gabapentin (4% w/v, 169.3 mM) and carbamazepine (4% w/v, 233.6 mM) topical paste was then used to coat the inner walls of a six-well plate. The wells were then filled with 6 ml of culture medium. Thirty minutes of incubation were used in both the drug release and cellular morphology experiments as it was felt this was a realistic time for a topical medication to be present in the oral cavity. After 30-min incubation, the media were aspirated and sent for high-performance liquid chromatography (HPLC) analysis to establish the concentration of drug released from the topical paste. Replicate samples were analysed (Cardiff Toxicology Laboratories, Llandough Hospital, Penarth, UK). Cellular morphology. HaCat and OKF6-TERT1 cells were seeded on coverslips at 1 9 10 5 and 2 9 10 5 per well, respectively, in a 12-well plate with 2 ml of media as the final volume per well. After overnight incubation, the media were discarded and replaced with 2 ml of new media alone (control) or media containing one of the NMs at a concentration that reflected the HPLC findings in the drug release experiment. After 30-min incubation, media were then aspirated and stored at -20°C to be used later in antibody array assay. The coverslips were fixed and processed for SEM as described previously (31) .
Cytokine expression
An exploratory Human Inflammation Antibody Array C1 (RayBiotech â , Norcross, GA, USA) was used to investigate a number of cytokines expressed in duplicate samples of conditioned media that had been collected from cells exposed to NMs for 30 min. The cytokines present on the array were eotaxin-1, eotaxin-2, G-CSF, GM-CSF, IFN-c, IL-1a, IL1-b, IL-2, IL-3, IL-4, IL-6, IL-7, IL-8, IL-10, IL-11, IL-12p40, IL12p70, IL-13, I-309, TIMP-2. Membranes were treated following the manufacturer's instructions before being developed on highly sensitive Amersham Hyperfilm ECL for 2 min.
Statistical analysis
Simple descriptive statistics and one-way ANOVA followed by Bonferroni post hoc tests were conducted in SPSS version 22 (SPSS Inc., Chicago, IL, USA).
Results

Cell viability
Cumulative NMs effect
In vitro effects of pure NMs on HaCat cellular viability are shown in Fig. 1 . HaCat cellular viability was significantly reduced by both low (200 lM) and high (1.8 mM) amitriptyline concentrations compared to untreated controls (P < 0.05). Carbamazepine exposure significantly reduced cellular viability only at high (1.7 mM) concentrations and after 2 h of exposure (P < 0.05), whilst gabapentin significantly reduced viability only at high (5.54 mM) concentra- HaCat cell exposure to low concentrations of carbamazepine and gabapentin at all time points produced no significant changes compared with controls (P > 0.05).
In oral keratinocyte cells (OKF6-TERT1, Fig. 2 ), significant reductions in viability (P < 0.05) were observed after exposure to amitriptyline at low (200 lM) concentrations for 4 h and high (1.8 mM) concentrations for 2 h. Similar observations were found for carbamazepine after exposure to high (1.7 mM) concentrations for 4 h. Neither concentration of gabapentin significantly affected cellular viability compared with controls (P > 0.05).
The median lethal dose (LD 50 ) of amitriptyline in HaCat cells (Fig. S1 ) was 512 and 186 lM at 30 min and 24 h, respectively. For carbamazepine, the LD 50 value for HaCat cells was 398 lM after 24-h exposure (Fig. S2) . Gabapentin had no LD 50 effect (Fig. S3) . In OKF6-TERT1 cells, the only LD 50 for amitriptyline was 630 lM after 24-h exposure.
Effect of NMs at specific time points
Exposure of HaCat cells to 200 lM and 1.8 mM amitriptyline for 30 min and 24 h significantly reduced their viability compared with controls (P < 0.05). Exposure to high concentrations of carbamazepine (1.7 mM) for 24 h also resulted in a significant loss of viability (P < 0.05) (Fig. 3) . Gabapentin showed no significant effect on cellular viability compared with control.
Short-term (30 min) exposure of OKF6-TERT1 cells to amitriptyline, carbamazepine and gabapentin at all concentrations significantly decreased cellular viability compared with untreated controls (P < 0.05, Fig. 4 ). Both amitriptyline concentrations and high concentrations of carbamazepine and gabapentin significantly reduced the viability of OKF6-TERT1 cells after longer exposure (24 h), (P < 0.05, Fig. 4) .
The only LD 50 value was for amitriptyline exposure at 30 min (141 lM), (Figs S4-S6 ).
Cell count
Using the calibration curve, the estimated number of HaCat cells was less than 5000 after 30-min exposure to amitriptyline at low (200 lM) and high (1.8 mM) concentrations. At the 24 h time point, the cell count was less than 1000 (Fig. S7 ). Exposure to low (100 lM) and high (1.7 mM) concentrations of carbamazepine for 30 min caused a similar reduction in cell counts. However, after 24-h exposure to 100 lM carbamazepine, cell counts were similar to controls. High concentration of carbamazepine reduced cell counts to less than 1000 (Fig. S8) . Gabapentin exposure for 30 min had no significant effects on cell counts, but after 24-h exposure to 150 lM gabapentin, cell counts were less than 10 000 (Fig. S9) .
In OKF6-TERT1 cells, exposure to low concentration of amitriptyline (200 lM) for 30 min reduced cell counts by half to 10 000 (Fig. S10) . High concentration of amitriptyline (1.8 mM) reduced the cell count to <2000 after 30 min, whilst after exposure to high and low concentrations for 24 h cell counts reduced to less than 200.
Exposure to carbamazepine at both low (150 lM) and high (1.7 mM) concentrations for 30 min had no effects on cell counts. After 24-h exposure to both concentrations, cell counts dropped to 15 000 (Fig. S11 ). Exposure to gabapentin at low (150 lM) and high (5.45 mM) concentrations for 30 min or 24 h had no effects on cell counts (Fig. S12) .
Drug release and cellular morphology
High-performance liquid chromatography analysis of the aspirated media after 30-min incubation with Orabase paste, containing amitriptyline (2% w/v), carbamazepine (4% w/v) and gabapentin (4% w/v), demonstrated the transfer of 226 lM, 123.9 lM and 5.54 mM drug concentrations, respectively, in the media.
Scanning electron microscopy revealed considerable changes in the cellular attachment and morphology of HaCat and OKF6-TERT1 cells exposed to 226 lM amitriptyline only (Figs 5 and S13 ).
Global cytokine expression
There were no significant differences in the expression of twenty different inflammatory cytokines between controls and both cell lines after 30-min exposure to the NMs at 
Discussion
Neuropathic OFP can be challenging to manage because of the limited number of proven interventions available (32) .
This difficulty and patient frustration with side effects (6) may have driven the move towards topical compounded NMs, based upon a reasonable hypothesis about the advantages this route of administration may offer (33) . However, compounded formulations are not without their problems (34) and represent a challenge and a responsibility to the prescriber from a safety and efficacy perspective (35) .
Prior to commencing any Phase I clinical trial for a new drug, the U.S. Food and Drug Administration (FDA) requires detailed preclinical data for that drug that includes cytotoxicity (36) . In these in vitro cytotoxicity studies, the typical tissues examined for systemically administered drugs are target, metabolism and excretion tissues. In the case of topical NMs that are applied on orofacial tissues in higher concentrations, the NMs are approved for systemic (oral) administration, but their toxic effects have not been examined as a result of changing their route of administration to topically applied higher concentrations, and this must therefore be examined preclinically (37) .
This in vitro study tested the effect of three NMs on cellular viability, count and morphology in addition to inflammatory response. Regarding viability, two exposure methods were used: cumulative drug and specific time point effects.
There are limited reports in the literature regarding the in vitro cytotoxicity of amitriptyline, but those that are present demonstrate cytotoxicity in both human and animal cell lines attributed to different mechanisms including the following: mitochondrial dysfunction, increased production of reactive oxygen species leading to alteration in cellular metabolism and permeability and elevated intracellular oxidative stress (24, 38) . In the current study, amitriptyline reduced cellular viability and cell counts in both cell lines at all concentrations and all time points, and SEM examination confirmed these findings. The cytotoxicity of amitriptyline was also demonstrated in its LD 50 values, which were low in both cell lines and after short exposure times.
The apoptotic and antiproliferative effects of carbamazepine have been investigated mainly in neurone and glial cell culture, using much lower concentrations than presented here (39, 40) . Comparing to amitriptyline, in the current study, carbamazepine was less cytotoxic in both cell lines, and major changes in viability only occurred at high concentrations and longer exposure times. SEM revealed no major changes in the cellular morphology and attachment. The LD 50 values were also confirmatory as they were calculable only after a cumulative exposure of 24 h, which is not clinically realistic for the topical application of a gel in the oral cavity.
Gabapentin appeared to be the least cytotoxic of the agents tested. Only a high concentration and long exposure time (24 h) caused a demonstrable reduction in cellular viability. A LD 50 was not calculable. This is consistent with previous few reports in the literature (41) that employed lower concentrations of gabapentin in vitro than the current study.
In our experiments, using an array approach, there was very low level of detected cytokine expression, with all NMs applied, and the cytokine expression did not differ significantly to untreated cells. This could be due to the short exposure time (30 min) used or the lack of sensitivity of the method used to measure cytokine expression.
The major limitation of this study is its use of a monolayer culture, which is conceivably more susceptible to the cytotoxic effects of medications than a more complex three-dimensional tissue model. However, the laboratory concentrations of NMs used in viability and counting experiments were much lower than those used in clinical practice and yet still demonstrated cytotoxicity. The concentrations employed also mirrored the ranges of drug concentrations used in the drug release experiment.
Within the limits of this investigation, the clinical implications for future topical in vivo NM trials are that low gabapentin and carbamazepine concentrations are unlikely to adversely affect oral mucosa and skin. However, if amitriptyline is to be trialled in vivo, short exposure times and very low concentrations with the careful clinical assessment of skin and oral mucosa after repeated exposure are advisable.
Conclusions
Viability, cell counting and SEM experiments revealed that amitriptyline was cytotoxic to both oral and skin keratinocyte cells in vitro. Gabapentin and carbamazepine affected cellular viability to a lesser extent, even at high concentrations and long exposures. Caution should be exercised in the topical application of amitriptyline to skin and oral mucosa.
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